Breaking News

Federal Appeals Court Unanimously Upholds Mississippi’s 340B Contract Pharmacy Access Law Against AbbVie Challenge

The U.S. 5th Circuit Court of Appeals affirmed a lower court's ruling denying AbbVie's bid to block enforcement of Mississippi's 340B contract pharmacy access law.
A federal appeals court today unanimously upheld Mississippi’s 340B contract pharmacy access law, rejecting AbbVie’s bid to block enforcement of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Publishes More Stakeholder Comments on Controversial 340B Rebate Pilot Proposal

HRSA has published 1,116 of the 1,243 comments it received on its controversial proposed 340B rebate pilot.
The Health Resources and Services Administration (HRSA) has now published 1,116 of the 1,243 comments it received on its controversial [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Four Drugmakers to Refund 340B Covered Entities for Overcharges

Four major drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024.
Four major drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024, following recalculations [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Carter, Harshbarger Reintroduce Controversial 340B ACCESS Act in U.S. House—This Time Without a Key Supporter

Two Republican U.S. House members reintroduced the controversial 340B ACCESS Act on Sept. 10.
Two key U.S. House Republicans and vocal 340B program critics on Wednesday reintroduced controversial 340B overhaul legislation—but unlike last year’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Federal Appeals Court Holds Combative Oral Arguments on Maryland and West Virginia’s 340B Contract Pharmacy Access Laws

The U.S. 4th Circuit Court of Appeals heard oral arguments on challenges to Maryland and West Virginia's 340B contract pharmacy access laws.
A tough-questioning federal appeals court panel yesterday held back-to-back oral arguments on drug industry legal challenges to Maryland and West [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

More than 1,200 Stakeholders Comment on HRSA’s Controversial 340B Rebate Pilot

Stakeholders submitted 1,243 comments to HRSA on its contentious 340B rebate pilot program before the Sept. 8 deadline.
The Health Resources and Services Administration (HRSA) received more than 1,200 comments on its controversial 340B rebate pilot program ahead [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

North Dakota Officials Transfer PhRMA’s State 340B Contract Pharmacy Lawsuit to Federal Court

North Dakota officials recently transferred a PhRMA lawsuit from a state courthouse to the U.S. District Court for the District of North Dakota.
North Dakota officials have transferred a drug industry lawsuit over the state’s new 340B contract pharmacy access law from state [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bipartisan Group of U.S. House Members Urges Colleagues to Sign onto Letter Opposing HHS’ 340B Rebate Pilot

Four members of the U.S. House are asking colleagues to sign onto a letter urging HHS to abandon its 340B rebate pilot program.
A bipartisan group of U.S. House members is circulating a draft letter urging HHS to abandon its controversial 340B rebate pilot program.
A bipartisan group of U.S. House members is circulating a draft letter urging the Department of Health and Human Services [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Targets 340B Hospitals in Reported ‘Seven Figure’ Ad Campaign—Its ‘Biggest’ 340B Ad Expenditure Yet

PhRMA released a 30-second television spot targeting the 340B program as part of a reported seven-figure campaign that will run in the Washington D.C.-area through the end of 2025.
Washington D.C.’s most powerful drug industry trade group this week ramped up its attacks on the 340B program, launching what’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Mitsubishi Tanabe Pharma Latest Drugmaker to Place 340B Contract Pharmacy Restrictions, Others Add New Drugs, State Exemptions

Mitsubishi Tanabe Pharma America became the 39th drugmaker to enact 340B contract pharmacy restrictions.
A New Jersey-based pharmaceutical manufacturer recently became the 39th drugmaker to enact 340B contract pharmacy restrictions.  Mitsubishi Tanabe Pharma America [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live